SavedAdd your journal

Journals / Ankara Üniversitesi Veteriner Fakültesi Dergisi / 2026 / Volume: 73 Issue: 2

Protective effect of alpha lipoic acid against oxidative damage caused by valproic acid on lung tissue in rats

Royal Shirinov(İstanbul University-Cerrahpaşa, Faculty of Engineering, Department of Chemistry, İstanbul, Türkiye.)0009-0003-0620-8400
İsmet Burcu Türkyılmaz(İstanbul University-Cerrahpaşa, Faculty of Engineering, Department of Chemistry, İstanbul, Türkiye.)0000-0003-2789-5943
Eda Dağsuyu(İstanbul University-Cerrahpaşa, Faculty of Engineering, Department of Chemistry, İstanbul, Türkiye.)0000-0003-0395-1058
Refiye Yanardağ(İstanbul University-Cerrahpaşa, Faculty of Engineering, Department of Chemistry, İstanbul, Türkiye.)0000-0003-4185-4363
Pages
—
Publication Date
2026-01-22
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a result, it may be concluded that ALA exerts protective effects against VPA-induced lung damage.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Valproic acid (VPA) is a short-chain fatty acid used to treat disorders of the brain.
📊
Key Findings & Data:The 1st group served as the control (1 mL olive oil); the 2nd group received ALA (50 mg/kg/day) for 15 days; the 3rd group received VPA (0.5 g/kg/day) for 15 days; and the 4th group received both VPA and ALA at the same doses and for the same duration.
💡
Conclusion & Impact:As a result, it may be concluded that ALA exerts protective effects against VPA-induced lung damage.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Free radicals · lipoic acid · lung

Abstract

Valproic acid (VPA) is a short-chain fatty acid used to treat disorders of the brain. When VPA is used for long term, it causes damage, particularly through the formation of free radicals. The lungs are among the organs most affected by long-term VPA treatment. Some antioxidant substances are used to prevent damage caused by free radicals. One of these substances is alpha-lipoic acid (ALA), which occurs naturally. In our study, the protective effect of ALA against VPA-induced lung injury was investigated. In this study, female Sprague-Dawley rats were divided into four groups. The 1st group served as the control (1 mL olive oil); the 2nd group received ALA (50 mg/kg/day) for 15 days; the 3rd group received VPA (0.5 g/kg/day) for 15 days; and the 4th group received both VPA and ALA at the same doses and for the same duration. ALA and VPA were dissolved in olive oil. On day 16, all groups were euthanized under anesthesia. The lung tissues were collected and homogenized. In the prepared supernatants, the levels of reduced glutathione and total antioxidant status, and the activities of glutathione reductase, glutathione peroxidase, catalase, paraoxonase, carbonic anhydrase, aryl esterase, and superoxide dismutase were decreased in the VPA group, while sialic acid, lipid peroxidation, reactive oxygen species, total oxidant, oxidative stress index, hydroxyproline, glycoprotein levels, and xanthine oxidase activities were increased in the VPA group. These values were reversed in ALA when VPA was administered. As a result, it may be concluded that ALA exerts protective effects against VPA-induced lung damage.

🔖

Cite This Article

Shirinov, R., Türkyılmaz, İ. B., Dağsuyu, E., Yanardağ, R. (2026). Protective effect of alpha lipoic acid against oxidative damage caused by valproic acid on lung tissue in rats. Ankara Üniversitesi Veteriner Fakültesi Dergisi, Volume: 73 Issue: 2. https://doi.org/10.33988/auvfd.1731146

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (49)

  1. Aebi H (1984): Catalase in vitro. Methods Enzymol, 105, 121–126.
  2. Alev-Tuzuner B, Ak E, Tunali S, et al (2024): Assessing the protective effects of chard on valproic acid-induced pancreatic complications. Indian J Biochem Biophys, 61, 517-526.
  3. Al-Shehri SS, Duley JA, Bansal N (2020): Xanthine oxidase- lactoperoxidase system and innate immunity: biochemical actions and physiological roles. Redox Biol, 34, 101524.
  4. Bayrak BB, Yilmaz S, Hacihasanoglu Cakmak N, et al (2021): The effects of edaravone, a free-radical scavenger in lung injury induced by valproic acid demonstrated via different biochemical parameters. J Biochem Mol Toxicol, 35, e22847.
  5. Beutler E (1971): Red cell metabolism. 68–70. In: A Manual of Biochemical Methods, Academic Press. London.
  6. Beutler E (1975): Reduced Glutathione. 112-114. In: Bergmeyer, H.V., Ed., Red Blood Cell Metabolism: A Manual of Biochemical Methods, 2nd Edition, Grune and Stratton, New York.
  7. Celik E, Tunali S, Gezginci-Oktayoglu S, et al (2021): Vitamin U prevents valproic acid-induced liver injury through supporting enzymatic antioxidant system and increasing hepatocyte proliferation triggered by inflammation and apoptosis. Toxicol Mech Methods, 31, 600-608.
  8. Corte ED, Stirpe F (1968): Regulation of xanthine oxidase in rat liver. Biochem J, 108, 349-351.
  9. Dagsuyu E, Magaji UF, Sacan O, et al (2023): Moringa oleifera ethanolic extract prevents oxidative damage on lens caused by sodium valproate used in epilepsy treatment. Eur J Biol, 82, 289-295.
  10. De Fátima Martins M, Honório-Ferreira A, Reis MS, et al (2020): Sialic acids expression in newborn rat lungs: implications for pulmonary developmental biology. Acta Histochem, 122, 151626.
  11. Dische Z, Shettles LB (1948): A specific color reaction of methylpentoses and a spectrophotometric micromethod for their determination. J Biol Chem, 175, 595-603.
  12. Doré M, San Juan AE, Frenette AJ, et al (2017): Clinical importance of monitoring unbound valproic acid concentration in patients with hypoalbuminemia. Pharmacotherapy, 37, 900–907.
  13. Du S, Ai J, Zeng X, et al (2016): Plasma level of advanced oxidation protein products as a novel biomarker of acute lung injury following cardiac surgery. SpringerPlus, 5, 231.
  14. Elik G, Oktay S, Turkyilmaz İB, et al (2024): Dermatoprotective effect of Moringa oleifera leaf extract on sodiumvalproate-induced skin damage in rats. Drug Chem Toxicol, 47, 1257–1266.
  15. Erel O (2004): A novel automated direct measurement method for total antioxidant capacity using a new generation. Clin Biochem, 37, 277–285.
  16. Erel O (2005): A new automated colorimetric method for measuring total oxidant status. Clin Biochem, 38, 1103–1111.
  17. Ertik O, Koroglu P, Magaji UF, et al (2025): Treatment of oxidative damage caused by valproic acid in tongue tissue with ethanolic Moringa oleifera leaves extract and prediction of potential bioactive molecules with molecular docking. J Mol Histol, 56, 37.
  18. Feng JF, Lu L, Zeng P, et al (2012): Serum total oxidant/antioxidant status and trace element levels in breast cancer patients. Int J Clin Oncol, 17, 575–583.
  19. Furlong CE, Richter RJ, Seidel SL, et al (1988): Role of genetic polymorphism of human plasma paraoxonase/arylesterase in hydrolysis of the insecticide metabolites chlorpyrifos oxon and paraoxon. Am J Hum Gen, 43, 230–238.
  20. Gan KN, Smolen A, Eckerson HW, et al (1991): Purification of human serum paraoxonase/arylesterase: evidence for one esterase catalyzing both activities. Drug Metab Dispos, 19, 100-106.
  21. Goličnik M, Bavec A (2020): Evaluation of the paraoxonase-1 kinetic parameters of the lactonase activity by nonlinear fit of progress curves. J Enzyme Inhib Med Chem, 35, 261-264.
  22. Habig WH, Jakoby WB (1981): Assays for differentiation of glutathione-S-transferases. Methods Enzymol, 77, 398–405.
  23. Hirad AH, Alarfaj AA, Ravindran B, et al (2025): Betanin inspired zinc oxide nanoparticles: The potential antioxidant and anticancer activity against human lung cancer cell line (A549). Biochem Biophys Res Commun, 742, 151019.
  24. Ibrahim Fouad GR, Mousa M (2021): The protective potential of alpha lipoic acid on amiodarone-induced pulmonary fibrosis and hepatic injury in rats. Mol Cell Biochem, 476, 3433-3448.
  25. Ledwozyw A, Michalak J, Stepien A, et al (1986): The relationship between plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atheroschlerosis. Clin Chim Acta, 155, 275–283.
  26. Lorentz K, Weiss T, Kraas E (1986): Sialic acid in human serum and cerebrospinal fluid. J Clin Chem Clin Biochem, 24, 189–198.
  27. Lowry OH, Rosebrough HJ, Farr AL, et al (1951): Protein measurement with the folin phenol reagent. J Biol Chem, 193, 265-275.
  28. Magaji UF, Koroglu P, Coremen M, et al (2025): Effects of Moringa oleifera extract on biochemical and histological parameters of sodium valproate induced lungs damage. J Mol Histol, 56, 56.
  29. Mylroie AA, Collins H, Umbles C, et al (1986): Erythrocyte SOD activity and other parameters of copper status in rats ingesting lead acetate. Toxicol Appl Pharmacol, 82, 512–520.
  30. Oztay F, Tunali S, Kayalar O, et al (2020): The protective effect of vitamin U on valproic acid-induced lung toxicity in rats via amelioration of oxidative stress. J Biochem Mol Toxicol, 35, e22602.
  31. Özerkan D, Ertik O, Kaya B, et al (2019): Novel palladium (II) complexes with tetradentate thiosemicarbazones. Synthesis, characterization, in vitro cytotoxicity and xanthine oxidase inhibition. Invest New Drugs, 37, 1187-1197.
  32. Öztaylan Y, Türkyılmaz İB, Yanardağ R (2022): The effects of alpha lipoic acid on lens injury in rats administered with valproic acid. J Ist Faculty Med, 85, 557-563.
  33. Patel VN, Patel HV, Agrawal K, et al (2024): Comprehensive developmental investigation on simvastatin enriched bioactivefilm forming spray using the quality by design paradigm: a prospective strategyfor improved wound healing, J Drug Target, 32, 1139-1153.
  34. Reddy GK, Enwemeka CS (1996): A simplified method for analysis of hydroxyproline in biological tissues. Clin Biochem, 29, 225-229.
  35. Rochette L, Ghibu S, Muresan A, et al (2015): Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes. Can J Physiol Pharmacol, 93, 1021-1027.
  36. Rogers LK, Cismowski MJ (2018): Oxidative stress in the lung- The essential paradox. Curr Opin Toxicol, 7, 37–43.
  37. Romoli M, Mazzocchetti M, D’Alonzo P, et al (2019): Valproic acid and epilepsy: from molecular mechanisms to clinical evidences. Curr Neuropharmacol, 17, 926–946.
  38. Shadid A, Nasir K, Bhatia M (2025): Therapuetic potential of alpha lipoic acid: Unraveling its role in oxidative stress and inflammatory conditions. Curr Issues Mol Biol, 47, 322.
  39. Shi Y, Wei Z, Feng Y, et al (2025): The diagnosis and treatment of disorders of nucleic acid/nucleotide metabolism associated with epilepsy. Acta Epileptol, 7, 23.
  40. Superti F, Russo G (2024): Alpha-lipoic acid: Biological mechanisms and health benefits. Antioxidants, 13, 1228.
  41. Verpoorte JA, Mehta S, Edsall JT (1967): Esterase activities of human carbonic anhydrases B and C. J Biol Chem, 242, 4221-4229.
  42. Victoria R (2017): Metabolism and physiological effects of carbon dioxide. Implications in anaesthetic management, Moldovan Med J, 60, 42-45.
  43. Wendel A (1981): Glutathione peroxidase. Methods Enzymol, 77, 325–333.
  44. Winzler RJ (1955): Determinations of serum glycoproteins. Methods Biochem Anal, 2, 279-311.
  45. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, et al (1996): Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int, 49, 1304- 1313.
  46. Wu C, Men C, Wang Y, et al. (2025): α-Lipoic acid maintains quality by modulating phenolic metabolism and antioxidant capacity in postharvest strawberry. Postharvest Biol Technol, 223, 113457
  47. Yuruk AA, Ayaz A (2014): Effects of alpha lipoic acid on health. Hacettepe Univ J Fac Health Sci, 1, 11-23.
  48. Yunusoglu O, Koyuncu E (2025): Alpha-lipoic acid in pharmaceutical development: a comprehensive review of its therapeutic potential and molecular mechanisms. Prospect Pharm Sci, 23, 67-86.
  49. Zhang Y, Che J, Ji H, et al. (2018): Suppression of endoplasmic reticulum stress activation in streptozotocin induced diabetic rat model. BMC Complement Altern Med, 18, 343.